# Vaccination Against Influenza to Prevent Cardiovascular Events After Acute Coronary Syndromes

Study · id `cardio:ct-nct04001504` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04001504](<https://clinicaltrials.gov/study/NCT04001504>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04001504

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1801 participants.

## Technical summary

Registry record NCT04001504. Randomized; single masking; primary purpose treatment. Start 2019-07-19 (actual); primary completion 2022-08-28 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1801 participants (enrolled count; ClinicalTrials.gov record NCT04001504, source copy `cardio:ctgov-nct04001504-2022-08-31`, retrieved 2026-10-31)
- Started: 2019-07-19 (actual) (ClinicalTrials.gov record NCT04001504, source copy `cardio:ctgov-nct04001504-2022-08-31`, retrieved 2026-10-31)
- Primary completion: 2022-08-28 (actual) (ClinicalTrials.gov record NCT04001504, source copy `cardio:ctgov-nct04001504-2022-08-31`, retrieved 2026-10-31)
- Completion: 2022-08-28 (actual) (ClinicalTrials.gov record NCT04001504, source copy `cardio:ctgov-nct04001504-2022-08-31`, retrieved 2026-10-31)
- Countries: Brazil (ClinicalTrials.gov record NCT04001504, source copy `cardio:ctgov-nct04001504-2022-08-31`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04001504-2022-08-31`, retrieved 2026-10-31)

## The registry's words

- Brief title: Vaccination Against Influenza to Prevent Cardiovascular Events After Acute Coronary Syndromes
- Acronym: VIP-ACS
- Condition: Acute Coronary Syndrome
- Intervention (Biological): Double Dose Quadrivalent Influenza Vaccine
- Intervention (Biological): Standard Dose Quadrivalent Influenza Vaccine
- Lead sponsor: Hospital Israelita Albert Einstein
- Lead sponsor class: OTHER
- Collaborator: Ministry of Health, Brazil
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)
- Registry lists this organization as the lead sponsor: Hospital Israelita Albert Einstein (`cardio:org-hospital-israelita-albert-einstein`)
- Registry lists this organization as a collaborator: Ministry of Health, Brazil (`cardio:org-ministry-of-health-brazil`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial (`cardio:pubmed-36030400`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Influenza vaccination for prevention of death and major cardiovascular events in patients with a history of stroke: A subanalysis of the VIP-ACS trial (`cardio:pubmed-40973981`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0f30214a57530a02753181ad99db21bedb945ef47f8bae844f5f4ec28b9e6a59
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
